OVID (Ovid Therapeutics Inc. Common Stock) Stock Analysis - Community
Ovid Therapeutics Inc. Common Stock (OVID) is a publicly traded Healthcare sector company. As of May 21, 2026, OVID trades at $2.42 with a market cap of $449.80M and a P/E ratio of 0.00. OVID moved -0.42% today. Year to date, OVID is +43.98%; over the trailing twelve months it is +724.71%. Its 52-week range spans $0.24 to $3.11. Analyst consensus is strong buy with an average price target of $5.33. Rallies surfaces OVID's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade OVID?
Rallies community data for OVID shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Rallies community data for OVID shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for OVID?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for OVID when enough community data is available.
Is OVID research on Rallies investment advice?
No. Rallies provides research, data, and educational context for OVID. It does not provide personalized investment advice.